# MindWalk Holdings Corp. (HYFT)

> Source: Nexqual · https://nexqual.com/HYFT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, MindWalk Holdings Corp. (HYFT), nexqual.com/HYFT" · informational, not investment advice.

**Price:** USD 1.4 (+2.19% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.37 · day 1.34–1.4 · 52w 0.99–2.99 · market cap $66.0M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 4.33 (range 3–5).
- Total return with dividends: 1Y -14.6% vs S&P 500 +18.1%; 5Y -78.7% vs S&P 500 +85.1%.
- Next earnings: 2026-09-14, EPS estimate USD -0.06, revenue estimate $4.3M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 4.33 (low 3, high 5).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -14.6% | -78.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -14.7% | -26.6% |
| Volatility (annualized) | 89.9% | 95.5% |
| Max drawdown | -63.3% (Jan 2026→Mar 2026) | -94.8% (Oct 2021→Feb 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/HYFT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt